CompletedNot Applicable

Short Stay Unit vs Hospitalization in Acute Heart Failure

United States194 participantsStarted 2017-12-06

Plain-language summary

The majority of the over one million annual AHF hospitalizations originate from the emergency department. Admitting and re-admitting lower risk AHF patients who don't need prolonged hospitalization may increase their risk for poor outcomes and decrease their quality of life: Safe alternatives to hospitalization from the ED are needed. We propose a strategy-of-care, short stay unit management of AHF (i.e. less than 24 hours), will lead to improved outcomes for lower risk AHF patients.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ED physician clinical diagnosis of AHF;
✓. Planned admission for AHF
✓. Systolic blood pressure \> 100mmHg, heart rate \< 115bpm\*
✓. Previous history of HF \*Patients with atrial fibrillation but controlled HR are eligible

Exclusion criteria

✕. Transplanted organ of any kind or ventricular assist device patient;
✕. End stage renal disease, on dialysis, or eGFR \< 20 mL/min;
✕. Acute coronary syndrome (e.g. EKG changes consistent with ischemia or troponin elevation secondary to ACS);
✕. Other acute co-morbid conditions (e.g. sepsis, altered mental status) that are unlikely to be treated within a SSU stay;
✕. Patients who require ventilatory support of any kind or intravenous vasodilators/vasopressor/inotropic support. Patients who receive a one-time dose of an intravenious vasodiolator, but are no longer on this medication, are eligible.
✕. Pregnant patients or any patient who has been pregnant in the last 3 months
✕. \< 18 years of age
✕. Any patient who in the opinion of the clinician or investigator requires hospitalization or ICU level care or will require rehabilitation or skilled nursing after discharge from the ED or hospital

What they're measuring

Days Alive and Out of Hospital

Timeframe: 30 day outcome

Trial details

NCT IDNCT03302910

SponsorIndiana University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-22

Results submitted2024-03-18

View on ClinicalTrials.gov More Acute Heart Failure trials